RNA, U4 small nuclear 29, pseudogene (RNU4-29P)

RNU4-29P is annotated as a pseudogene for a U4 small nuclear RNA, meaning it is a non-functional genomic locus related to, but distinct from, the functional snRNA genes that encode the U4 small nuclear RNA component of the spliceosome. Unlike its functional counterparts (such as RNU4-2), RNU4-29P does not produce an active RNA or protein product and does not participate in the assembly or function of spliceosomal complexes. There is no evidence that RNU4-29P plays any direct role in disease, biological processes, or as a drug target[1]. Context and justification: - RNU4-29P is consistently annotated as a pseudogene, which by definition is a non-functional remnant of a gene[1]. - Functional spliceosome components, such as those encoded by RNU4-2, have clear roles in splicing and recent disease associations (e.g., neurodevelopmental disorders), but no such roles are described or supported for RNU4-29P across gene databases or biomedical literature[1][3][4][5][6]. - Pseudogenes do not encode active gene products, are not considered therapeutic targets, and are not associated with interacting drugs, mechanisms of action, or biomarker roles in clinical contexts. - No evidence of biological function, disease relation, or druggability exists for RNU4-29P, affirming that it is not a valid therapeutic target and correcting any misinterpretation that it might encode a functional molecule. Note: You may be seeking information on functional U4 small nuclear RNAs (such as RNU4-2), which do play essential biological and disease roles, but RNU4-29P itself is not functionally relevant in these aspects[1].

Other names

RNU4-29P